SCHEMBL12008500

SCHEMBL12008500

O=C(O)CCN1C(=O)/C(=C/c2ccccc2OCc2ccccc2Cl)SC1=S

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 2/20 0.71
▸ POLB P06746 8/20 0.69
▸ KMT2A Q03164 8/20 0.69
▸ USP2 O75604 2/20 0.69
▸ NCOA1 Q15788 1/20 0.69
▸ L3MBTL1 Q9Y468 1/20 0.69
▸ NCOA3 Q9Y6Q9 1/20 0.69
▸ MEN1 O00255 6/20 0.68
▸ DNMT1 P26358 1/20 0.68
▸ BLM P54132 1/20 0.68
▸ CASP6 P55212 1/20 0.64
▸ CTNNB1 P35222 1/20 0.60
▸ TCF7L2 Q9NQB0 1/20 0.60
▸ CISD1 Q9NZ45 2/20 0.58
▸ MAOA P21397 1/20 0.58
▸ APAF1 O14727 1/20 0.58
▸ ADAMTS5 Q9UNA0 1/20 0.58
▸ GFER P55789 1/20 0.56
▸ TAS2R14 Q9NYV8 1/20 0.55
▸ MAP3K5 Q99683 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12008517 0.94 POLB (0.78) PPARGPOLBKMT2AUSP2NCOA1
SCHEMBL12008443 0.87 POLB (0.89) PPARGPOLBKMT2AUSP2NCOA1
SCHEMBL12008483 0.87 POLB (0.85) PPARGPOLBKMT2AUSP2NCOA1
SCHEMBL12008501 0.87 PPARG (0.83) PPARGPOLBKMT2AUSP2NCOA1
SCHEMBL6883788 0.85 PPARG (0.74) PPARGPOLBKMT2AL3MBTL1MEN1
SCHEMBL12008505 0.85 AKR1B1 (0.72) POLBKMT2ANCOA3MEN1CISD1
SCHEMBL12008790 0.85 PPARG (0.76) PPARGPOLBKMT2AMEN1CISD1
SCHEMBL12008442 0.84 PPARG (0.75) PPARGPOLBKMT2ANCOA3MEN1
SCHEMBL12008507 0.83 KMT2A (0.71) POLBKMT2ANCOA3MEN1DNMT1
SCHEMBL12008494 0.83 PPARG (0.74) PPARGPOLBKMT2ANCOA3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170049751-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF DASGUPTA RAMANUJ (US) 2017-02-23 — — US disclosed
US-20170049751-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF DASGUPTA RAMANUJ (US) 2017-02-23 — — US disclosed
US-9433611-B2 Oxazole and thiazole compounds as β-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2016-09-06 — — US disclosed
US-9433611-B2 Oxazole and thiazole compounds as β-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2016-09-06 — — US disclosed
US-9173871-B2 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2015-11-03 — — US disclosed
US-9173871-B2 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2015-11-03 — — US disclosed
US-20130109675-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF NEW YORK UNIVERSITY 2013-05-02 — — US disclosed
US-20130109675-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF NEW YORK UNIVERSITY 2013-05-02 — — US disclosed
US-20120264744-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF UNITED STATES GOVERNMENT 2012-10-18 — — US disclosed
US-20120264744-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF UNITED STATES GOVERNMENT 2012-10-18 — — US disclosed
US-8252823-B2 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2012-08-28 — — US disclosed
US-8252823-B2 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof NEW YORK UNIVERSITY (US) 2012-08-28 — — US disclosed
US-20090227624-A1 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof US ARMY, SECRETARY OF THE ARMY 2009-09-10 — — US disclosed
US-20090227624-A1 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof US ARMY, SECRETARY OF THE ARMY 2009-09-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120264744-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF CTNNB1, CTNNA1, CTNNBL1 PPARG 295/4885POLB 2397/4885KMT2A 4503/4885
US-20090227624-A1 Oxazole and thiazole compounds as beta-catenin modulators and uses thereof CTNNB1, CTNNA1, CTNNBL1 PPARG 152/4885POLB 2088/4885KMT2A 4591/4885
US-20170049751-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF CTNNB1, CTNNA1, CTNNBL1 PPARG 152/4885POLB 2088/4885KMT2A 4591/4885
US-20130109675-A1 OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF CTNNB1, CTNNA1, CTNNBL1 PPARG 152/4885POLB 2088/4885KMT2A 4591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback